POORLY DIFFERENTIATED FORMS OF PAPILLARY THYROID-CARCINOMA - DISTINCTIVE ENTITIES OR MORPHOLOGICAL PATTERNS

被引:0
|
作者
PILOTTI, S
COLLINI, P
MANZARI, A
MARUBINI, E
RILKE, F
机构
关键词
THYROID NEOPLASMS; PAPILLARY CARCINOMA; TUMOR DIFFERENTIATION; MORPHOLOGY; PROGNOSIS; ODDS RATIO; SURVIVAL DATA;
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The concept that poorly differentiated carcinomas (PDC) represent a group in an intermediate position in the spectrum of follicular cell-derived carcinomas of the thyroid gland is currently well established. Because at the well-differentiated end of the spectrum there are two groups of entities with distinct biological characteristics, ie, the papillary carcinoma (PC) and the follicular carcinoma (FC), we examined the group represented by PCs to ascertain whether papillary carcinoma-related PDCs (pPDC) represent merely a histologic variant or a distinct pathologic entity. For this purpose 227 consecutive PCs were reclassified according to current criteria. The association between the presence of a tumoral pattern consistent with pPDC (response variable), and prognostic factors such as gender age, pTNM (predictive variables) was evaluated in terms of odds ratio statistics. One hundred eighty-three of 227 cases, defined as PCs met the World Health Organization criteria of the not otherwise specified (NOS) (79 cases), microcarcinoma (65 cases), encapsulated (4 cases) and follicular (35 cases) variants. Forty-four cases, defined as pPDCs, met those of the tall cell (39 cases), columnar cell PC (2 cases) and mixed tall cell-columnar cell PC (3 cases) variants, Statistical analyses of the two groups of patients showed a significant correlation between differentiation and age above 40 years, extrathyroid tumor extension and low ratio of regional nodal involvement at the onset of disease. More strikingly they also showed that morphology, ie, a tumoral pattern consistent with pPDC (differentiation), is the strongest predictor of biological behavior including recurrences and recurrence-related deaths that appear to occur five and twenty times more frequently in pPDCs than in PCs, respectively. On the basis of these findings, we conclude that pPDCs represent a distinct high-risk clinicopathologic entity among PCs. Copyright (C) 1995 by W.B. Saunders Company
引用
收藏
页码:249 / 255
页数:7
相关论文
共 50 条
  • [1] FOLLICULAR VARIANT OF PAPILLARY THYROID-CARCINOMA - A CLINICOPATHOLOGICAL STUDY
    TIELENS, ET
    SHERMAN, SI
    HRUBAN, RH
    LADENSON, PW
    CANCER, 1994, 73 (02) : 424 - 431
  • [2] HIGHLY INVASIVE PAPILLARY THYROID-CARCINOMA
    HEFER, T
    JOACHIMS, HZ
    EITAN, A
    GOLZ, A
    BROWN, J
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1994, 108 (10) : 889 - 891
  • [3] POORLY DIFFERENTIATED (INSULAR) CARCINOMA OF THE THYROID
    MIZUKAMI, Y
    NONOMURA, A
    MICHIGISHI, T
    NOGUCHI, M
    OHMURA, K
    NAKAMURA, S
    HOSO, M
    PATHOLOGY INTERNATIONAL, 1995, 45 (09) : 663 - 668
  • [4] Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma
    Asakawa, H
    Kobayashi, T
    Komoike, Y
    Maruyama, H
    Nakano, Y
    Tamaki, Y
    Matsuzawa, Y
    Monden, M
    ANTICANCER RESEARCH, 1997, 17 (4A) : 2757 - 2762
  • [5] RECURRENCE AND MORTALITY IN PATIENTS WITH DIFFERENTIATED THYROID-CARCINOMA
    NOGUCHI, M
    YAGI, H
    EARASHI, M
    KINOSHITA, K
    MIYAZAKI, I
    MIZUKAMI, Y
    INTERNATIONAL SURGERY, 1995, 80 (02) : 162 - 166
  • [6] Clinicopathological significance of poorly differentiated thyroid carcinoma
    Nishida, T
    Katayama, S
    Tsujimoto, M
    Nakamura, J
    Matsuda, H
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (02) : 205 - 211
  • [7] INSULAR VARIANT OF POORLY DIFFERENTIATED THYROID CARCINOMA
    Fat, Ioana
    Kulaga, Mark
    Dodis, Regina
    Carling, Tobias
    Theoharis, Constantine
    Rennert, Nancy J.
    ENDOCRINE PRACTICE, 2011, 17 (01) : 115 - 121
  • [8] Poorly differentiated thyroid carcinoma An underdiagnosed entity
    Dettmer, M. S.
    Schmitt, A.
    Komminoth, P.
    Perren, A.
    PATHOLOGE, 2020, 41 (SUPPL 1): : 1 - 8
  • [9] CURRENTLY ACCEPTED PLAN FOR THE TREATMENT OF DIFFERENTIATED THYROID-CARCINOMA
    ROKA, R
    NIEDERLE, B
    GNANT, M
    LANGLE, F
    HAUSMANINGER, C
    NEUHOLD, N
    CHIRURG, 1991, 62 (07): : 518 - 523
  • [10] Papillary Thyroid Carcinoma with High-Grade Features Versus Poorly Differentiated Thyroid Carcinoma: An Analysis of Clinicopathologic and Molecular Features and Outcome
    Wong, Kristine S.
    Dong, Fei
    Telatar, Milhan
    Lorch, Jochen H.
    Alexander, Erik K.
    Marqusee, Ellen
    Cho, Nancy L.
    Nehs, Matthew A.
    Doherty, Gerard M.
    Afkhami, Michelle
    Barletta, Justine A.
    THYROID, 2021, 31 (06) : 933 - 940